Cargando…
Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249185/ https://www.ncbi.nlm.nih.gov/pubmed/30411203 http://dx.doi.org/10.1007/s40121-018-0221-2 |
| _version_ | 1783372688083910656 |
|---|---|
| author | Wilson, Michele R. Wasserman, Matt Jadavji, Taj Postma, Maarten Breton, Marie-Claude Peloquin, Francois Earnshaw, Stephanie R. McDade, Cheryl Sings, Heather L. Farkouh, Raymond |
| author_facet | Wilson, Michele R. Wasserman, Matt Jadavji, Taj Postma, Maarten Breton, Marie-Claude Peloquin, Francois Earnshaw, Stephanie R. McDade, Cheryl Sings, Heather L. Farkouh, Raymond |
| author_sort | Wilson, Michele R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6249185 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62491852018-12-06 Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” Wilson, Michele R. Wasserman, Matt Jadavji, Taj Postma, Maarten Breton, Marie-Claude Peloquin, Francois Earnshaw, Stephanie R. McDade, Cheryl Sings, Heather L. Farkouh, Raymond Infect Dis Ther Letter Springer Healthcare 2018-11-08 2018-12 /pmc/articles/PMC6249185/ /pubmed/30411203 http://dx.doi.org/10.1007/s40121-018-0221-2 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter Wilson, Michele R. Wasserman, Matt Jadavji, Taj Postma, Maarten Breton, Marie-Claude Peloquin, Francois Earnshaw, Stephanie R. McDade, Cheryl Sings, Heather L. Farkouh, Raymond Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” |
| title | Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” |
| title_full | Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” |
| title_fullStr | Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” |
| title_full_unstemmed | Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” |
| title_short | Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” |
| title_sort | response to mcgirr et al.'s comment on “clinical and economic impact of a potential switch from 13-valent to 10-valent pneumococcal conjugate infant vaccination in canada” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249185/ https://www.ncbi.nlm.nih.gov/pubmed/30411203 http://dx.doi.org/10.1007/s40121-018-0221-2 |
| work_keys_str_mv | AT wilsonmicheler responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT wassermanmatt responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT jadavjitaj responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT postmamaarten responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT bretonmarieclaude responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT peloquinfrancois responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT earnshawstephanier responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT mcdadecheryl responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT singsheatherl responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada AT farkouhraymond responsetomcgirretalscommentonclinicalandeconomicimpactofapotentialswitchfrom13valentto10valentpneumococcalconjugateinfantvaccinationincanada |